Fig. 9From: Combined with UPLC-Triple-TOF/MS-based plasma lipidomics and molecular pharmacology reveals the mechanisms of schisandrin against Alzheimer’s diseaseA the Control group; B the Model group; C the Sch group; D the TO90 group; E apoptosis rates of different groups of cells (**p < 0.01)Back to article page